Doxorubicin-resistant chronic myeloid leukemia cells enhanced phosphorylation of STAT3 and dampened the tumor growth inhibition of TNF-α. The gene discussed is TNF; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.